Clinical Trial Update: A Vaccine (PolyPEPI1018 Vaccine) and TAS-102 for the Treatment of Metastatic Colorectal Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the combination of PolyPEPI1018 vaccine and TAS-102 in metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Colorectal Cancer Microsatellite-stable
• Rectal Cancer

Drugs mentioned

• PolyPEPI1018 Vaccine (PolyPEPI1018 vaccine)
• TAS-102 (Lonsurf) (trifluridine/tipiracil)

Snippet

Sponsor: Mayo Clinic | Conditions: Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma | Phase 1 | Status: COMPLETED